DART Therapeutics Appoints Gene Williams as CEO

On September 10th MBBP client DART Therapeutics LLC announced it has named its new Executive Team including co-founder and executive chairman, Gene W. Williams as its CEO. Founded in 2010 by Williams and patient foundations the Nash Avery Foundation and Charley’s Fund, DART is a patient-funded biotech business focused on Duchenne Muscular Dystrophy (DMD) and other …

Continue reading DART Therapeutics Appoints Gene Williams as CEO

Dart Therapeutics Featured in Wall Street Journal Health Blog

On December 27th, the Wall Street Journal's Heath Blog published a post on MBBP client Dart Therapeutics, a company focused on developing treatment for Duchenne muscular dystrophy (DMD).  Dart Therapeutics was formed by two families, the Secklers and Wickas, who each have a son diagnosed with DMD, a genetic neuromuscular disorder. They were frustrated with the lack of …

Continue reading Dart Therapeutics Featured in Wall Street Journal Health Blog